Tuberculin skin test overestimates tuberculosis hypersensitivity in adult patients with psoriasis

Dermatology

Volumn 219, Issue 2, 2009, Pages 119-125

  Tsiouri, G ^a   Gaitanis, G ^a   Kiorpelidou, D ^a   Dionysiou, A ^a   Efthymiou, A ^a   Daskalopoulos, G ^a   Constantopoulos, S ^a   Bassukas, I D ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b University Campus ^*  (Greece)

Author keywords

Biological agents; Latent tuberculosis infection; Psoriasis; Tuberculin skin test; Tuberculosis

Indexed keywords

TUBERCULIN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DERMATOLOGY; DISEASE SEVERITY; FEMALE; HUMAN; HYPERSENSITIVITY; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSORIASIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SKIN INDURATION; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; COHORT STUDIES; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROBABILITY; PSORIASIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TUBERCULIN TEST; TUBERCULOSIS;

EID: 69349102420     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000222431     Document Type: Article

References (40)

1. Keane J: Tumor necrosis factor blockers and reactivation of latent tuberculosis. Clin Infect Dis 2004; 39: 300-302. (Pubitemid 39050475)
2. Gomez-Reino JJ, Carmona L, Angel DM: Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum 2007; 57: 756-761. (Pubitemid 46932080)
3. Menzies D, Pai M, Comstock G: Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354. (Pubitemid 351650594)
4. Huebner RE, Schein MF, Bass JB Jr: The tuberculin skin test. Clin Infect Dis 1993; 17: 968-975.
5. Taylor Z, Nolan CM, Blumberg HM, American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America: Controlling tuberculosis in the United States: recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep 2005; 54: 1-81.
6. Furst DE, Breedveld FC, Kalden JR, Smolen JS, Burmester GR, Sieper J, Emery P, Keystone EC, Schiff MH, Mease P, van Riel PL, Fleischmann R, Weisman MH, Weinblatt ME: Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007. Ann Rheum Dis 2007; 66 (suppl 3):2-22. (Pubitemid 350032626)
7. Lebwohl M, Bagel J, Gelfand JM, Gladman D, Gordon KB, Hsu S, Kalb RE, Kimball AB, Korman NJ, Krueger GG, Mease P, Morison WL, Paller A, Pariser DM, Ritchlin C, Strober B, Van Voorhees A, Weinstein GD, Young M, Horn L: From the medical board of the national psoriasis foundation: monitoring and vaccinations in patients treated with biologics for psoriasis. J Am Acad Dermatol 2008; 58: 94-105. (Pubitemid 350302037)
8. Doherty SD, Van Voorhees A, Lebwohl MG, Korman NJ, Young MS, Hsu S, National Psoriasis Foundation: National psoriasis foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents. J Am Acad Dermatol 2008; 59: 209-217.
9. Méndez J, García I, Escudero G, Marcos M, Sánchez A, Cabrerizoa S: Generalized pustular psoriasis induced by tuberculin testing. Actas Dermosifiliogr 2007; 98: 506-507. (Pubitemid 47360705)
10. McFadden JP, Powels AV, Baker BS, Valdimarsson H, Fry L: Intradermal antigen tests in psoriasis. Acta Derm Venereol 1990; 70: 262-264.
11. White MI, Noble WC: Consequences of colonization and infection by Staphylococcus aureus in atopic dermatitis. Clin Exp Dermatol 1986; 11: 34-40.
12. Dogan B, Harmanyeri Y: Intradermal antigen tests and the Köbner phenomenon in psoriasis. Int J Dermatol 1997; 36: 263-265. (Pubitemid 27242617)
13. Lindholm L, Magnusson BL, Mobacken H: Depressed non-specific lymphocyte reactivity in psoriasis. Arch Dermatol Res 1978; 10: 121-125. (Pubitemid 9051533)
14. Sachs L: Angewandte Statistik, ed 7, rev. Berlin, Springer, 1992.
15. Grossman J, Baum J, Gluckman J, Fusner J, Condemi JJ: The effect of aging and acute illness on delayed hypersensitivity. J Allergy Clin Immunol 1975; 55: 268-275.
16. Starr S, Berkovich S: Effects of measles, gamma-globulin-modified measles and vaccine measles on the tuberculin test. N Engl J Med 1964; 270: 386-391.
17. Henseler T, Christophers E: Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-986.
18. Krueger JG, Bowcock A: Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005; 64: 30-36.
19. Bachelez H: Immunopathogenesis of psoriasis: recent insights on the role of adaptive and innate immunity. J Autoimmun 2005; 25: 69-73. (Pubitemid 41728048)
20. Bos JD: Psoriasis, innate immunity, and gene pools. J Am Acad Dermatol 2007; 56: 468-471.
21. Lowes MA, Bowcock AM, Krueger JG: Pathogenesis and therapy of psoriasis. Nature 2007; 445: 866-873.
22. Pedrosa J, Saunders B, Appleberg R, Orme I, Silva M, Cooper A: Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect Immun 2000; 68:577-583.
23. Fulton S, Reba S, Martin T, Boom W: Neutrophil-mediated mycobactericidal immunity in the lung during Mycobacterium bovis BCG infection in C57BL/6 mice. Infect Immun 2002; 70: 5322-5327.
24. Morel C, Badell E, Adabie V, Robledo M, Setterblad N, Gluckman JC, Gicquel B, Boudaly S, Winter N: Mycobacterium bovis BCG-infected neutrophils and dendritic cells cooperate to induce specific T cell responses in humans and mice. Eur J Immunol 2008; 38: 437-447.
25. Granucci F, Vizzardelli C, Pavelka N, Feau S, Persico M, Virzi E, Rescigno M, Moro G, Ricciardi-Castagnoli P: Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol 2001; 2: 882-888. (Pubitemid 34906455)
26. Algood HMS, Lin PL, Flynn JAL: Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis 2005; 41: S189-S193.
27. Bos JD, De Rie MA, Teunissen MBM, Piskin G: Psoriasis: dysregulation of innate immunity. Br J Dermatol 2005; 152: 1098-1107.
28. Curry JL, Qin JZ, Robinson J, Nickoloff BJ: Reactivity of resident immunocytes in normal and prepsoriatic skin using an ex vivo skin-explant model system. Arch Pathol Lab Med 2003; 127: 289-296. (Pubitemid 36378691)
29. Vissers WH, Arndtz CH, Muys L, Van Erp PE, de Jong EM, van de Kerkhof PC: Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late. Br J Dermatol 2004; 150: 852-859. (Pubitemid 38903516)
30. Komine M, Karakawa M, Takekoshi T, Sakurai N, Minatani Y, Mitsui H, Tada Y, Saeki H, Asahina A, Tamaki K: Early inflammatory changes in the 'perilesional skin' of psoriatic plaques: Is there interaction between dendritic cells and keratinocytes? J Invest Dermatol 2007; 127: 1915-1922.
31. Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O, Burg G, Liu YJ, Gilliet M: Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. J Exp Med 2005; 202: 135-143. (Pubitemid 41002916)
32. Nestle FO, Turka LA, Nickoloff BJ: Characterization of dermal dendritic cells in psoriasis: autostimulation of T lymphocytes and induction of Th1 type cytokines. J Clin Invest 1994; 94: 202-209. (Pubitemid 24218093)
33. Eriksen KW, Lovato P, Skov L, Krejsgaard T, Kaltoft K, Geisler C, Ødum N: Increased sensitivity to interferon-alpha in psoriatic T cells. J Invest Dermatol 2005; 125: 936-944.
34. Nickoloff BJ, Karabin GD, Barker JN, Griffiths CE, Sarma V, Mitra RS, Elder JT, Kunkel SL, Dixit VM: Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol 1991; 138: 129-140.
35. Stratis A, Pasparakis M, Rupec RA, Markur D, Hartmann K, Scharffetter-Kochanek K, Peters T, van Rooijen N, Krieg T, Haase I: Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J Clin Invest 2006; 116: 2094-2104. (Pubitemid 44162318)
36. Wang H, Peters T, Kess D, Sindrilaru A, Oreshkova T, Van Rooijen N, Stratis A, Renkl AC, Sunderkötter C, Wlaschek M, Haase I, Scharffetter-Kochanek K: Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J Clin Invest 2006; 116: 2105-2114. (Pubitemid 44162319)
37. Rambukkana A, Das PK, Witkamp L, Yong S, Meinardi MM, Bos JD: Antibodies to mycobacterial 65-kDa heat shock protein and other immunodominant antigens in patients with psoriasis. J Invest Dermatol 1993; 100: 87-92. (Pubitemid 23035911)
38. Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Bishai WR, Iademarco MF, Rothel JS: Comparison of a whole-blood interferon γ assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001; 286: 1740-1747.
39. Lein AD, Fordham von Reyn C, Ravn P, Horsburgh C, Alexander L, Andersen P: Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis . Clin Diagn Lab Immunol 1999; 6: 606-609. (Pubitemid 29330751)
40. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A, Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC): Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54: 49-55.